PMID- 37148553 OWN - NLM STAT- MEDLINE DCOM- 20230724 LR - 20230725 IS - 1531-8257 (Electronic) IS - 0885-3185 (Linking) VI - 38 IP - 6 DP - 2023 Jun TI - Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation. PG - 937-948 LID - 10.1002/mds.29415 [doi] AB - Closed-loop adaptive deep brain stimulation (aDBS) can deliver individualized therapy at an unprecedented temporal precision for neurological disorders. This has the potential to lead to a breakthrough in neurotechnology, but the translation to clinical practice remains a significant challenge. Via bidirectional implantable brain-computer-interfaces that have become commercially available, aDBS can now sense and selectively modulate pathophysiological brain circuit activity. Pilot studies investigating different aDBS control strategies showed promising results, but the short experimental study designs have not yet supported individualized analyses of patient-specific factors in biomarker and therapeutic response dynamics. Notwithstanding the clear theoretical advantages of a patient-tailored approach, these new stimulation possibilities open a vast and mostly unexplored parameter space, leading to practical hurdles in the implementation and development of clinical trials. Therefore, a thorough understanding of the neurophysiological and neurotechnological aspects related to aDBS is crucial to develop evidence-based treatment regimens for clinical practice. Therapeutic success of aDBS will depend on the integrated development of strategies for feedback signal identification, artifact mitigation, signal processing, and control policy adjustment, for precise stimulation delivery tailored to individual patients. The present review introduces the reader to the neurophysiological foundation of aDBS for Parkinson's disease (PD) and other network disorders, explains currently available aDBS control policies, and highlights practical pitfalls and difficulties to be addressed in the upcoming years. Finally, it highlights the importance of interdisciplinary clinical neurotechnological research within and across DBS centers, toward an individualized patient-centered approach to invasive brain stimulation. (c) 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. CI - (c) 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. FAU - Neumann, Wolf-Julian AU - Neumann WJ AUID- ORCID: 0000-0002-6758-9708 AD - Movement Disorder and Neuromodulation Unit, Department of Neurology, Charite-Universitatsmedizin Berlin, Berlin, Germany. FAU - Gilron, Roee AU - Gilron R AD - Rune Labs, San Francisco, California, USA. FAU - Little, Simon AU - Little S AD - Movement Disorders and Neuromodulation Centre, University of California San Francisco, San Francisco, California, USA. FAU - Tinkhauser, Gerd AU - Tinkhauser G AUID- ORCID: 0000-0002-1954-1873 AD - Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland. LA - eng GR - K23 NS120037/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20230506 PL - United States TA - Mov Disord JT - Movement disorders : official journal of the Movement Disorder Society JID - 8610688 SB - IM MH - Humans MH - *Deep Brain Stimulation/methods MH - *Parkinson Disease/therapy MH - Neurophysiology OTO - NOTNLM OT - Parkinson's disease OT - adaptive DBS OT - basal ganglia OT - closed loop DBS OT - local field potentials EDAT- 2023/05/06 19:42 MHDA- 2023/07/24 06:42 CRDT- 2023/05/06 15:36 PHST- 2023/03/27 00:00 [revised] PHST- 2022/07/21 00:00 [received] PHST- 2023/04/05 00:00 [accepted] PHST- 2023/07/24 06:42 [medline] PHST- 2023/05/06 19:42 [pubmed] PHST- 2023/05/06 15:36 [entrez] AID - 10.1002/mds.29415 [doi] PST - ppublish SO - Mov Disord. 2023 Jun;38(6):937-948. doi: 10.1002/mds.29415. Epub 2023 May 6.